Maravai LifeSciences Holdings, Inc. MRVI Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cygnus | $66.22M+0.4% | $65.96M+0.9% | $65.35M+1.7% | $64.25M+2.3% | $62.78M-0.1% | |
| TriLink | $138.51M+15.6% | $119.79M-5.7% | $127.09M-18.3% | $155.58M-13.1% | $179.08M-8.8% | |
| Restructuring by Business | ||||||
| Cygnus | $37.5K-30.6% | $54K— | —— | —— | —— | |
| TriLink | $12.5M-9.5% | $13.82M— | —— | —— | —— | |
| Other Restructuring Costs by Business | ||||||
| Cygnus | $2.25K-25.0% | $3K— | —— | —— | —— | |
| TriLink | $284.25K-25.0% | $379K— | —— | —— | —— | |
| Asset Impairments by Business | ||||||
| Corporate | $2.89M-25.0% | $3.86M— | —— | —— | —— | |
| Cygnus | $0— | $0— | —— | —— | —— | |
| TriLink | $8.72M-19.4% | $10.82M— | —— | —— | —— | |
| Severance Costs by Business | ||||||
| Cygnus | $35.25K-30.9% | $51K— | —— | —— | —— | |
| TriLink | $1.52M-42.0% | $2.62M— | —— | —— | —— | |
| Revenue by Geography | ||||||
| Asia Pacific | $38.79M-6.5% | $41.47M-15.3% | $48.96M-22.9% | $63.54M-19.4% | $78.8M-11.8% | |
| Europe, the Middle East and Africa | $45.99M+48.7% | $30.92M0.0% | $30.92M-9.9% | $34.32M-13.3% | $39.57M-5.9% | |
| Latin and Central America | $1.15M+18.8% | $971K+28.4% | $756K+29.2% | $585K+16.8% | $501K-24.3% | |
| North America | $118.8M+5.7% | $112.38M+0.5% | $111.8M-7.9% | $121.39M-1.3% | $122.99M-3.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Maravai LifeSciences Holdings, Inc. break its business down?
- Maravai LifeSciences Holdings, Inc. (MRVI) reports revenue by business across 2 parts — Cygnus and TriLink. Each is extracted from the segment footnotes and tracked over time.
- Where does Maravai LifeSciences Holdings, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Maravai LifeSciences Holdings, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
